SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-21-000100
Filing Date
2021-08-09
Accepted
2021-08-09 16:15:35
Documents
15
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20210809.htm   iXBRL 8-K 39006
2 EX-99.1 q22021financialresultsrele.htm EX-99.1 112859
6 GRAPHIC tricidalogoa03.jpg GRAPHIC 6561
7 GRAPHIC tcda-20210809_g1.jpg GRAPHIC 5018
  Complete submission text file 0001595585-21-000100.txt   327962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20210809.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20210809_lab.xml EX-101.LAB 25149
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20210809_pre.xml EX-101.PRE 13056
8 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20210809_htm.xml XML 11390
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 211156674
SIC: 2834 Pharmaceutical Preparations